Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-517248-73-00Phase 4Authorised
Phase 4, single-arm trial of platelet-rich plasma in erectile dysfunction (ED), sponsored by Boston Medical Group. Primary endpoint: Change in IIEF-EF score between baseline and week 21. Planned start Aug 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-517248-73-00.